In the context of p53 activation and its post-translational changes, compound 23 was similarly effective as cisplatin, in all ovarian cancer cells, which is of particular importance for A2780 and A2780cis cells expressing wt p53. This evidence concerns the gene TP53 and ovarian cancer.